Sarepta Therapeutics

Director, Patient Focused Drug Development and Innovation

Sarepta Therapeutics • $185K — $232K *
Pharmaceuticals & Biotech
11 - 15 years of experience

About Sarepta Therapeutics

Sarepta Therapeutics, Inc. is an American biotechnology company focused on the discovery and development of RNA-targeted therapeutics. The company's lead product candidate is eteplirsen, a treatment for Duchenne muscular dystrophy (DMD). The company is also developing other RNA-targeted therapeutics for the treatment of other neuromuscular and infectious diseases. Sarepta Therapeutics was founded in 1980 as AntiVirals, Inc. and changed its name to AVI BioPharma, Inc. in 2000. The company changed its name to Sarepta Therapeutics, Inc. in 2012.
Learn more about Sarepta Therapeutics
Size
840 employees
Market Cap
$11.3 billion
Industry
Net Income
-$554.1 million
Founded
1980
5 Year Trend
+164.5%
Revenue
$540.1 million
NASDAQ

Similar Jobs

More Jobs at Sarepta Therapeutics

More Pharmaceuticals & Biotech Jobs

* Ladders Estimates